CD4 and Miyoshi myopathy: In the present study, we showed that pretransplant proportion of CD3+CD4+CD161+ T cells in patients with MM undergoing ASCT can predict the occurrence of early complications, suggesting that CD161-expressing T cells play an important role in the inflammatory milieu.